APO Research
Talk to an analyst

APO RESEARCH · REPORT

Terbinafine Hydrochloride Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Terbinafine Hydrochloride Drug Market Analysis and Forecast 2026-2032

20 December 2025208 pages

Choose your research edition.

Industry ResearchTerbinafine Hydrochloride Drug Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Terbinafine Hydrochloride Drug Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Terbinafine Hydrochloride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Terbinafine Hydrochloride Drug Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Terbinafine Hydrochloride Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Terbinafine Hydrochloride Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Terbinafine Hydrochloride Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Terbinafine Hydrochloride Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Terbinafine Hydrochloride Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Terbinafine Hydrochloride Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Terbinafine Hydrochloride Drug include APOTEX, Breckenridge Pharmaceutical, CIPLA LTD, Cussess, Dr. Reddy's Laboratories, Glenmark, Harris Pharmaceutical, InvaGen Pharmaceuticals and Orchid Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Terbinafine Hydrochloride Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Terbinafine Hydrochloride Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Terbinafine Hydrochloride Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Terbinafine Hydrochloride Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Terbinafine Hydrochloride Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Terbinafine Hydrochloride Drug sales, projected growth trends, production technology, application and end-user industry.

Terbinafine Hydrochloride Drug Segment by Company

APOTEX

Breckenridge Pharmaceutical

CIPLA LTD

Cussess

Dr. Reddy's Laboratories

Glenmark

Harris Pharmaceutical

InvaGen Pharmaceuticals

Orchid Healthcare

TARO

GSK

Hubei Hengan Fulin Pharm

Jilin Wantong Group

Novartis

TEVA

Xiuzheng Pharmaceutical

Terbinafine Hydrochloride Drug Segment by Type

Topical

Oral

Terbinafine Hydrochloride Drug Segment by Application

Fingernail Infection

Toenail Infection

Others

Terbinafine Hydrochloride Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Terbinafine Hydrochloride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Terbinafine Hydrochloride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Terbinafine Hydrochloride Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Terbinafine Hydrochloride Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Terbinafine Hydrochloride Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Topical Major Manufacturers Table 3. Oral Major Manufacturers Table 4. Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Fingernail Infection Major Manufacturers Table 6. Toenail Infection Major Manufacturers Table 7. Others Major Manufacturers Table 8. Terbinafine Hydrochloride Drug Industry Trends Table 9. Terbinafine Hydrochloride Drug Industry Drivers Table 10. Terbinafine Hydrochloride Drug Industry Opportunities and Challenges Table 11. Terbinafine Hydrochloride Drug Industry Restraints Table 12. Global Terbinafine Hydrochloride Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Terbinafine Hydrochloride Drug Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Terbinafine Hydrochloride Drug Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2021-2026) Table 16. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2027-2032) Table 17. Global Terbinafine Hydrochloride Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Terbinafine Hydrochloride Drug Sales by Region (2021-2026) & (W Units) Table 19. Global Terbinafine Hydrochloride Drug Sales by Region (2027-2032) & (W Units) Table 20. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2021-2026) Table 21. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2027-2032) Table 22. Global Terbinafine Hydrochloride Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Terbinafine Hydrochloride Drug Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Terbinafine Hydrochloride Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2021-2026) Table 26. Global Terbinafine Hydrochloride Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Terbinafine Hydrochloride Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Terbinafine Hydrochloride Drug Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Terbinafine Hydrochloride Drug Manufacturers, Product Type & Application Table 30. Global Terbinafine Hydrochloride Drug Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Terbinafine Hydrochloride Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Terbinafine Hydrochloride Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Terbinafine Hydrochloride Drug Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Terbinafine Hydrochloride Drug Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2021-2026) Table 37. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2027-2032) Table 38. Global Terbinafine Hydrochloride Drug Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Terbinafine Hydrochloride Drug Sales by Type (2021-2026) & (W Units) Table 40. Global Terbinafine Hydrochloride Drug Sales by Type (2027-2032) & (W Units) Table 41. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2021-2026) Table 42. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2027-2032) Table 43. Global Terbinafine Hydrochloride Drug Price by Type (2021-2026) & (US$/Unit) Table 44. Global Terbinafine Hydrochloride Drug Price by Type (2027-2032) & (US$/Unit) Table 45. Global Terbinafine Hydrochloride Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Terbinafine Hydrochloride Drug Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Terbinafine Hydrochloride Drug Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2021-2026) Table 49. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2027-2032) Table 50. Global Terbinafine Hydrochloride Drug Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Terbinafine Hydrochloride Drug Sales by Application (2021-2026) & (W Units) Table 52. Global Terbinafine Hydrochloride Drug Sales by Application (2027-2032) & (W Units) Table 53. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2021-2026) Table 54. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2027-2032) Table 55. Global Terbinafine Hydrochloride Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Terbinafine Hydrochloride Drug Price by Application (2027-2032) & (US$/Unit) Table 57. APOTEX Company Information Table 58. APOTEX Business Overview Table 59. APOTEX Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. APOTEX Terbinafine Hydrochloride Drug Product Portfolio Table 61. APOTEX Recent Development Table 62. Breckenridge Pharmaceutical Company Information Table 63. Breckenridge Pharmaceutical Business Overview Table 64. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 66. Breckenridge Pharmaceutical Recent Development Table 67. CIPLA LTD Company Information Table 68. CIPLA LTD Business Overview Table 69. CIPLA LTD Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio Table 71. CIPLA LTD Recent Development Table 72. Cussess Company Information Table 73. Cussess Business Overview Table 74. Cussess Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Cussess Terbinafine Hydrochloride Drug Product Portfolio Table 76. Cussess Recent Development Table 77. Dr. Reddy's Laboratories Company Information Table 78. Dr. Reddy's Laboratories Business Overview Table 79. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio Table 81. Dr. Reddy's Laboratories Recent Development Table 82. Glenmark Company Information Table 83. Glenmark Business Overview Table 84. Glenmark Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Glenmark Terbinafine Hydrochloride Drug Product Portfolio Table 86. Glenmark Recent Development Table 87. Harris Pharmaceutical Company Information Table 88. Harris Pharmaceutical Business Overview Table 89. Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 91. Harris Pharmaceutical Recent Development Table 92. InvaGen Pharmaceuticals Company Information Table 93. InvaGen Pharmaceuticals Business Overview Table 94. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio Table 96. InvaGen Pharmaceuticals Recent Development Table 97. Orchid Healthcare Company Information Table 98. Orchid Healthcare Business Overview Table 99. Orchid Healthcare Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio Table 101. Orchid Healthcare Recent Development Table 102. TARO Company Information Table 103. TARO Business Overview Table 104. TARO Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. TARO Terbinafine Hydrochloride Drug Product Portfolio Table 106. TARO Recent Development Table 107. GSK Company Information Table 108. GSK Business Overview Table 109. GSK Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. GSK Terbinafine Hydrochloride Drug Product Portfolio Table 111. GSK Recent Development Table 112. Hubei Hengan Fulin Pharm Company Information Table 113. Hubei Hengan Fulin Pharm Business Overview Table 114. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio Table 116. Hubei Hengan Fulin Pharm Recent Development Table 117. Jilin Wantong Group Company Information Table 118. Jilin Wantong Group Business Overview Table 119. Jilin Wantong Group Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio Table 121. Jilin Wantong Group Recent Development Table 122. Novartis Company Information Table 123. Novartis Business Overview Table 124. Novartis Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Novartis Terbinafine Hydrochloride Drug Product Portfolio Table 126. Novartis Recent Development Table 127. TEVA Company Information Table 128. TEVA Business Overview Table 129. TEVA Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. TEVA Terbinafine Hydrochloride Drug Product Portfolio Table 131. TEVA Recent Development Table 132. Xiuzheng Pharmaceutical Company Information Table 133. Xiuzheng Pharmaceutical Business Overview Table 134. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio Table 136. Xiuzheng Pharmaceutical Recent Development Table 137. North America Terbinafine Hydrochloride Drug Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Terbinafine Hydrochloride Drug Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Terbinafine Hydrochloride Drug Sales by Type (2021-2026) & (W Units) Table 140. North America Terbinafine Hydrochloride Drug Sales by Type (2027-2032) & (W Units) Table 141. North America Terbinafine Hydrochloride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 142. North America Terbinafine Hydrochloride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 143. North America Terbinafine Hydrochloride Drug Revenue by Application (2021-2026) & (US$ Million) Table 144. North America Terbinafine Hydrochloride Drug Revenue by Application (2027-2032) & (US$ Million) Table 145. North America Terbinafine Hydrochloride Drug Sales by Application (2021-2026) & (W Units) Table 146. North America Terbinafine Hydrochloride Drug Sales by Application (2027-2032) & (W Units) Table 147. North America Terbinafine Hydrochloride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 148. North America Terbinafine Hydrochloride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 149. North America Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. North America Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. North America Terbinafine Hydrochloride Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 153. North America Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 154. North America Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 155. North America Terbinafine Hydrochloride Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 156. North America Terbinafine Hydrochloride Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 157. United States Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 158. Canada Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 159. Europe Terbinafine Hydrochloride Drug Revenue by Type (2021-2026) & (US$ Million) Table 160. Europe Terbinafine Hydrochloride Drug Revenue by Type (2027-2032) & (US$ Million) Table 161. Europe Terbinafine Hydrochloride Drug Sales by Type (2021-2026) & (W Units) Table 162. Europe Terbinafine Hydrochloride Drug Sales by Type (2027-2032) & (W Units) Table 163. Europe Terbinafine Hydrochloride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 164. Europe Terbinafine Hydrochloride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 165. Europe Terbinafine Hydrochloride Drug Revenue by Application (2021-2026) & (US$ Million) Table 166. Europe Terbinafine Hydrochloride Drug Revenue by Application (2027-2032) & (US$ Million) Table 167. Europe Terbinafine Hydrochloride Drug Sales by Application (2021-2026) & (W Units) Table 168. Europe Terbinafine Hydrochloride Drug Sales by Application (2027-2032) & (W Units) Table 169. Europe Terbinafine Hydrochloride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 170. Europe Terbinafine Hydrochloride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 171. Europe Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Europe Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Europe Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Europe Terbinafine Hydrochloride Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 175. Europe Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 176. Europe Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 177. Europe Terbinafine Hydrochloride Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 178. Europe Terbinafine Hydrochloride Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Germany Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 180. France Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 181. U.K. Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 182. Italy Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 183. Netherlands Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 184. China Terbinafine Hydrochloride Drug Revenue by Type (2021-2026) & (US$ Million) Table 185. China Terbinafine Hydrochloride Drug Revenue by Type (2027-2032) & (US$ Million) Table 186. China Terbinafine Hydrochloride Drug Sales by Type (2021-2026) & (W Units) Table 187. China Terbinafine Hydrochloride Drug Sales by Type (2027-2032) & (W Units) Table 188. China Terbinafine Hydrochloride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 189. China Terbinafine Hydrochloride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 190. China Terbinafine Hydrochloride Drug Revenue by Application (2021-2026) & (US$ Million) Table 191. China Terbinafine Hydrochloride Drug Revenue by Application (2027-2032) & (US$ Million) Table 192. China Terbinafine Hydrochloride Drug Sales by Application (2021-2026) & (W Units) Table 193. China Terbinafine Hydrochloride Drug Sales by Application (2027-2032) & (W Units) Table 194. China Terbinafine Hydrochloride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 195. China Terbinafine Hydrochloride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 196. Asia Terbinafine Hydrochloride Drug Revenue by Type (2021-2026) & (US$ Million) Table 197. Asia Terbinafine Hydrochloride Drug Revenue by Type (2027-2032) & (US$ Million) Table 198. Asia Terbinafine Hydrochloride Drug Sales by Type (2021-2026) & (W Units) Table 199. Asia Terbinafine Hydrochloride Drug Sales by Type (2027-2032) & (W Units) Table 200. Asia Terbinafine Hydrochloride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 201. Asia Terbinafine Hydrochloride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 202. Asia Terbinafine Hydrochloride Drug Revenue by Application (2021-2026) & (US$ Million) Table 203. Asia Terbinafine Hydrochloride Drug Revenue by Application (2027-2032) & (US$ Million) Table 204. Asia Terbinafine Hydrochloride Drug Sales by Application (2021-2026) & (W Units) Table 205. Asia Terbinafine Hydrochloride Drug Sales by Application (2027-2032) & (W Units) Table 206. Asia Terbinafine Hydrochloride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 207. Asia Terbinafine Hydrochloride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 208. Asia Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. Asia Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. Asia Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. Asia Terbinafine Hydrochloride Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 212. Asia Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 213. Asia Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 214. Asia Terbinafine Hydrochloride Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 215. Asia Terbinafine Hydrochloride Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 216. Japan Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 217. South Korea Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 218. India Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 219. Australia Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 220. China Taiwan Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 221. Southeast Asia Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 222. SAMEA Terbinafine Hydrochloride Drug Revenue by Type (2021-2026) & (US$ Million) Table 223. SAMEA Terbinafine Hydrochloride Drug Revenue by Type (2027-2032) & (US$ Million) Table 224. SAMEA Terbinafine Hydrochloride Drug Sales by Type (2021-2026) & (W Units) Table 225. SAMEA Terbinafine Hydrochloride Drug Sales by Type (2027-2032) & (W Units) Table 226. SAMEA Terbinafine Hydrochloride Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 227. SAMEA Terbinafine Hydrochloride Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 228. SAMEA Terbinafine Hydrochloride Drug Revenue by Application (2021-2026) & (US$ Million) Table 229. SAMEA Terbinafine Hydrochloride Drug Revenue by Application (2027-2032) & (US$ Million) Table 230. SAMEA Terbinafine Hydrochloride Drug Sales by Application (2021-2026) & (W Units) Table 231. SAMEA Terbinafine Hydrochloride Drug Sales by Application (2027-2032) & (W Units) Table 232. SAMEA Terbinafine Hydrochloride Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 233. SAMEA Terbinafine Hydrochloride Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 234. SAMEA Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. SAMEA Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. SAMEA Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. SAMEA Terbinafine Hydrochloride Drug Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 238. SAMEA Terbinafine Hydrochloride Drug Sales by Country (2021-2026) & (W Units) Table 239. SAMEA Terbinafine Hydrochloride Drug Sales by Country (2027-2032) & (W Units) Table 240. SAMEA Terbinafine Hydrochloride Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 241. SAMEA Terbinafine Hydrochloride Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 242. Brazil Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 243. Argentina Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 244. Chile Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 245. Colombia Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 246. Peru Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 247. Saudi Arabia Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 248. Israel Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 249. UAE Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 250. Turkey Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 251. Iran Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 252. Egypt Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Table 253. Key Raw Materials Table 254. Raw Materials Key Suppliers Table 255. Terbinafine Hydrochloride Drug Distributors List Table 256. Terbinafine Hydrochloride Drug Customers List Table 257. Research Programs/Design for This Report Table 258. Authors List of This Report Table 259. Secondary Sources Table 260. Primary Sources List of Figures Figure 1. Terbinafine Hydrochloride Drug Image Figure 2. Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Terbinafine Hydrochloride Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Topical Image Figure 5. Oral Image Figure 6. Global Terbinafine Hydrochloride Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Terbinafine Hydrochloride Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Fingernail Infection Image Figure 9. Toenail Infection Image Figure 10. Others Image Figure 11. Global Terbinafine Hydrochloride Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Terbinafine Hydrochloride Drug Revenue (2021-2032) & (US$ Million) Figure 13. Global Terbinafine Hydrochloride Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2021-2032) Figure 16. Global Terbinafine Hydrochloride Drug Sales (2021-2032) & (W Units) Figure 17. Global Terbinafine Hydrochloride Drug Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Terbinafine Hydrochloride Drug Sales YoY (2021-2032) & (W Units) Figure 20. Europe Terbinafine Hydrochloride Drug Sales YoY (2021-2032) & (W Units) Figure 21. China Terbinafine Hydrochloride Drug Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Terbinafine Hydrochloride Drug Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Terbinafine Hydrochloride Drug Sales YoY (2021-2032) & (W Units) Figure 24. Global Terbinafine Hydrochloride Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Terbinafine Hydrochloride Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Terbinafine Hydrochloride Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2021-2032) Figure 30. Global Terbinafine Hydrochloride Drug Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Terbinafine Hydrochloride Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2021-2032) Figure 33. Global Terbinafine Hydrochloride Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2021-2032) Figure 36. Global Terbinafine Hydrochloride Drug Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Terbinafine Hydrochloride Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2021-2032) Figure 39. North America Terbinafine Hydrochloride Drug Revenue Share by Type (2021-2032) Figure 40. North America Terbinafine Hydrochloride Drug Sales Share by Type (2021-2032) Figure 41. North America Terbinafine Hydrochloride Drug Revenue Share by Application (2021-2032) Figure 42. North America Terbinafine Hydrochloride Drug Sales Share by Application (2021-2032) Figure 43. North America Terbinafine Hydrochloride Drug Revenue Share by Country (2021-2032) Figure 44. North America Terbinafine Hydrochloride Drug Sales Share by Country (2021-2032) Figure 45. Europe Terbinafine Hydrochloride Drug Revenue Share by Type (2021-2032) Figure 46. Europe Terbinafine Hydrochloride Drug Sales Share by Type (2021-2032) Figure 47. Europe Terbinafine Hydrochloride Drug Revenue Share by Application (2021-2032) Figure 48. Europe Terbinafine Hydrochloride Drug Sales Share by Application (2021-2032) Figure 49. Europe Terbinafine Hydrochloride Drug Revenue Share by Country (2021-2032) Figure 50. Europe Terbinafine Hydrochloride Drug Sales Share by Country (2021-2032) Figure 51. China Terbinafine Hydrochloride Drug Revenue Share by Type (2021-2032) Figure 52. China Terbinafine Hydrochloride Drug Sales Share by Type (2021-2032) Figure 53. China Terbinafine Hydrochloride Drug Revenue Share by Application (2021-2032) Figure 54. China Terbinafine Hydrochloride Drug Sales Share by Application (2021-2032) Figure 55. Asia Terbinafine Hydrochloride Drug Revenue Share by Type (2021-2032) Figure 56. Asia Terbinafine Hydrochloride Drug Sales Share by Type (2021-2032) Figure 57. Asia Terbinafine Hydrochloride Drug Revenue Share by Application (2021-2032) Figure 58. Asia Terbinafine Hydrochloride Drug Sales Share by Application (2021-2032) Figure 59. Asia Terbinafine Hydrochloride Drug Revenue Share by Country (2021-2032) Figure 60. Asia Terbinafine Hydrochloride Drug Sales Share by Country (2021-2032) Figure 61. SAMEA Terbinafine Hydrochloride Drug Revenue Share by Type (2021-2032) Figure 62. SAMEA Terbinafine Hydrochloride Drug Sales Share by Type (2021-2032) Figure 63. SAMEA Terbinafine Hydrochloride Drug Revenue Share by Application (2021-2032) Figure 64. SAMEA Terbinafine Hydrochloride Drug Sales Share by Application (2021-2032) Figure 65. SAMEA Terbinafine Hydrochloride Drug Revenue Share by Country (2021-2032) Figure 66. SAMEA Terbinafine Hydrochloride Drug Sales Share by Country (2021-2032) Figure 67. Terbinafine Hydrochloride Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Terbinafine Hydrochloride Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Topical
  • Oral
Applications
  • Fingernail Infection
  • Toenail Infection
  • Others
Companies covered
  • APOTEX
  • Breckenridge Pharmaceutical
  • CIPLA LTD
  • Cussess
  • Dr. Reddy's Laboratories
  • Glenmark
  • Harris Pharmaceutical
  • InvaGen Pharmaceuticals
  • Orchid Healthcare
  • TARO
  • GSK
  • Hubei Hengan Fulin Pharm
  • Jilin Wantong Group
  • Novartis
  • TEVA
  • Xiuzheng Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Terbinafine Hydrochloride Drug Market by Type
  3. 1.2.1 Global Terbinafine Hydrochloride Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Topical
  5. 1.2.3 Oral
  6. 1.3 Terbinafine Hydrochloride Drug Market by Application
  7. 1.3.1 Global Terbinafine Hydrochloride Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Fingernail Infection
  9. 1.3.3 Toenail Infection
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Terbinafine Hydrochloride Drug Market Dynamics
  1. 2.1 Terbinafine Hydrochloride Drug Industry Trends
  2. 2.2 Terbinafine Hydrochloride Drug Industry Drivers
  3. 2.3 Terbinafine Hydrochloride Drug Industry Opportunities and Challenges
  4. 2.4 Terbinafine Hydrochloride Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Terbinafine Hydrochloride Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Terbinafine Hydrochloride Drug Revenue by Region
  3. 3.2.1 Global Terbinafine Hydrochloride Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Terbinafine Hydrochloride Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Terbinafine Hydrochloride Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Terbinafine Hydrochloride Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Terbinafine Hydrochloride Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Terbinafine Hydrochloride Drug Sales by Region
  9. 3.4.1 Global Terbinafine Hydrochloride Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Terbinafine Hydrochloride Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Terbinafine Hydrochloride Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Terbinafine Hydrochloride Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Terbinafine Hydrochloride Drug Revenue by Manufacturers
  2. 4.1.1 Global Terbinafine Hydrochloride Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Terbinafine Hydrochloride Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Terbinafine Hydrochloride Drug Sales by Manufacturers
  6. 4.2.1 Global Terbinafine Hydrochloride Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Terbinafine Hydrochloride Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Terbinafine Hydrochloride Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Terbinafine Hydrochloride Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Terbinafine Hydrochloride Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Terbinafine Hydrochloride Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Terbinafine Hydrochloride Drug Manufacturers, Product Type & Application
  13. 4.7 Global Terbinafine Hydrochloride Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Terbinafine Hydrochloride Drug Market CR5 and HHI
  16. 4.8.2 2025 Terbinafine Hydrochloride Drug Tier 1, Tier 2, and Tier 3
5 Terbinafine Hydrochloride Drug Market by Type
  1. 5.1 Global Terbinafine Hydrochloride Drug Revenue by Type
  2. 5.1.1 Global Terbinafine Hydrochloride Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Terbinafine Hydrochloride Drug Sales by Type
  6. 5.2.1 Global Terbinafine Hydrochloride Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Terbinafine Hydrochloride Drug Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Terbinafine Hydrochloride Drug Price by Type
6 Terbinafine Hydrochloride Drug Market by Application
  1. 6.1 Global Terbinafine Hydrochloride Drug Revenue by Application
  2. 6.1.1 Global Terbinafine Hydrochloride Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Terbinafine Hydrochloride Drug Sales by Application
  6. 6.2.1 Global Terbinafine Hydrochloride Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Terbinafine Hydrochloride Drug Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Terbinafine Hydrochloride Drug Price by Application
7 Company Profiles
  1. 7.1 APOTEX
  2. 7.1.1 APOTEX Company Information
  3. 7.1.2 APOTEX Business Overview
  4. 7.1.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio
  6. 7.1.5 APOTEX Recent Developments
  7. 7.2 Breckenridge Pharmaceutical
  8. 7.2.1 Breckenridge Pharmaceutical Company Information
  9. 7.2.2 Breckenridge Pharmaceutical Business Overview
  10. 7.2.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  12. 7.2.5 Breckenridge Pharmaceutical Recent Developments
  13. 7.3 CIPLA LTD
  14. 7.3.1 CIPLA LTD Company Information
  15. 7.3.2 CIPLA LTD Business Overview
  16. 7.3.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio
  18. 7.3.5 CIPLA LTD Recent Developments
  19. 7.4 Cussess
  20. 7.4.1 Cussess Company Information
  21. 7.4.2 Cussess Business Overview
  22. 7.4.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio
  24. 7.4.5 Cussess Recent Developments
  25. 7.5 Dr. Reddy's Laboratories
  26. 7.5.1 Dr. Reddy's Laboratories Company Information
  27. 7.5.2 Dr. Reddy's Laboratories Business Overview
  28. 7.5.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio
  30. 7.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 7.6 Glenmark
  32. 7.6.1 Glenmark Company Information
  33. 7.6.2 Glenmark Business Overview
  34. 7.6.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio
  36. 7.6.5 Glenmark Recent Developments
  37. 7.7 Harris Pharmaceutical
  38. 7.7.1 Harris Pharmaceutical Company Information
  39. 7.7.2 Harris Pharmaceutical Business Overview
  40. 7.7.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  42. 7.7.5 Harris Pharmaceutical Recent Developments
  43. 7.8 InvaGen Pharmaceuticals
  44. 7.8.1 InvaGen Pharmaceuticals Company Information
  45. 7.8.2 InvaGen Pharmaceuticals Business Overview
  46. 7.8.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio
  48. 7.8.5 InvaGen Pharmaceuticals Recent Developments
  49. 7.9 Orchid Healthcare
  50. 7.9.1 Orchid Healthcare Company Information
  51. 7.9.2 Orchid Healthcare Business Overview
  52. 7.9.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio
  54. 7.9.5 Orchid Healthcare Recent Developments
  55. 7.10 TARO
  56. 7.10.1 TARO Company Information
  57. 7.10.2 TARO Business Overview
  58. 7.10.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 TARO Terbinafine Hydrochloride Drug Product Portfolio
  60. 7.10.5 TARO Recent Developments
  61. 7.11 GSK
  62. 7.11.1 GSK Company Information
  63. 7.11.2 GSK Business Overview
  64. 7.11.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 GSK Terbinafine Hydrochloride Drug Product Portfolio
  66. 7.11.5 GSK Recent Developments
  67. 7.12 Hubei Hengan Fulin Pharm
  68. 7.12.1 Hubei Hengan Fulin Pharm Company Information
  69. 7.12.2 Hubei Hengan Fulin Pharm Business Overview
  70. 7.12.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio
  72. 7.12.5 Hubei Hengan Fulin Pharm Recent Developments
  73. 7.13 Jilin Wantong Group
  74. 7.13.1 Jilin Wantong Group Company Information
  75. 7.13.2 Jilin Wantong Group Business Overview
  76. 7.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio
  78. 7.13.5 Jilin Wantong Group Recent Developments
  79. 7.14 Novartis
  80. 7.14.1 Novartis Company Information
  81. 7.14.2 Novartis Business Overview
  82. 7.14.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio
  84. 7.14.5 Novartis Recent Developments
  85. 7.15 TEVA
  86. 7.15.1 TEVA Company Information
  87. 7.15.2 TEVA Business Overview
  88. 7.15.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio
  90. 7.15.5 TEVA Recent Developments
  91. 7.16 Xiuzheng Pharmaceutical
  92. 7.16.1 Xiuzheng Pharmaceutical Company Information
  93. 7.16.2 Xiuzheng Pharmaceutical Business Overview
  94. 7.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
  96. 7.16.5 Xiuzheng Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Terbinafine Hydrochloride Drug Market Size by Type
  2. 8.1.1 North America Terbinafine Hydrochloride Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Terbinafine Hydrochloride Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Terbinafine Hydrochloride Drug Price by Type (2021-2032)
  5. 8.2 North America Terbinafine Hydrochloride Drug Market Size by Application
  6. 8.2.1 North America Terbinafine Hydrochloride Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Terbinafine Hydrochloride Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Terbinafine Hydrochloride Drug Price by Application (2021-2032)
  9. 8.3 North America Terbinafine Hydrochloride Drug Market Size by Country
  10. 8.3.1 North America Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Terbinafine Hydrochloride Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Terbinafine Hydrochloride Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Terbinafine Hydrochloride Drug Market Size by Type
  2. 9.1.1 Europe Terbinafine Hydrochloride Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Terbinafine Hydrochloride Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Terbinafine Hydrochloride Drug Price by Type (2021-2032)
  5. 9.2 Europe Terbinafine Hydrochloride Drug Market Size by Application
  6. 9.2.1 Europe Terbinafine Hydrochloride Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Terbinafine Hydrochloride Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Terbinafine Hydrochloride Drug Price by Application (2021-2032)
  9. 9.3 Europe Terbinafine Hydrochloride Drug Market Size by Country
  10. 9.3.1 Europe Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Terbinafine Hydrochloride Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Terbinafine Hydrochloride Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Terbinafine Hydrochloride Drug Market Size by Type
  2. 10.1.1 China Terbinafine Hydrochloride Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Terbinafine Hydrochloride Drug Sales by Type (2021-2032)
  4. 10.1.3 China Terbinafine Hydrochloride Drug Price by Type (2021-2032)
  5. 10.2 China Terbinafine Hydrochloride Drug Market Size by Application
  6. 10.2.1 China Terbinafine Hydrochloride Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Terbinafine Hydrochloride Drug Sales by Application (2021-2032)
  8. 10.2.3 China Terbinafine Hydrochloride Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Terbinafine Hydrochloride Drug Market Size by Type
  2. 11.1.1 Asia Terbinafine Hydrochloride Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Terbinafine Hydrochloride Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Terbinafine Hydrochloride Drug Price by Type (2021-2032)
  5. 11.2 Asia Terbinafine Hydrochloride Drug Market Size by Application
  6. 11.2.1 Asia Terbinafine Hydrochloride Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Terbinafine Hydrochloride Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Terbinafine Hydrochloride Drug Price by Application (2021-2032)
  9. 11.3 Asia Terbinafine Hydrochloride Drug Market Size by Country
  10. 11.3.1 Asia Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Terbinafine Hydrochloride Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Terbinafine Hydrochloride Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Terbinafine Hydrochloride Drug Market Size by Type
  2. 12.1.1 SAMEA Terbinafine Hydrochloride Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Terbinafine Hydrochloride Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Terbinafine Hydrochloride Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Terbinafine Hydrochloride Drug Market Size by Application
  6. 12.2.1 SAMEA Terbinafine Hydrochloride Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Terbinafine Hydrochloride Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Terbinafine Hydrochloride Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Terbinafine Hydrochloride Drug Market Size by Country
  10. 12.3.1 SAMEA Terbinafine Hydrochloride Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Terbinafine Hydrochloride Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Terbinafine Hydrochloride Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Terbinafine Hydrochloride Drug Value Chain Analysis
  2. 13.1.1 Terbinafine Hydrochloride Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Terbinafine Hydrochloride Drug Production Mode & Process
  6. 13.2 Terbinafine Hydrochloride Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Terbinafine Hydrochloride Drug Distributors
  9. 13.2.3 Terbinafine Hydrochloride Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst